Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Methylphenidate
Brain Hypoxia - Ischemia
Massachusetts General HospitalP1CC (43)
Metoclopramide
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
Mezigdomide
Acute Myeloid Leukemia With Mutated NPM1
Massachusetts General HospitalP1CC (43)
MGC026
Castration-Resistant Prostate Carcinoma
MacroGenicsP1CC (43)
MGC026
Esophageal Squamous Cell Carcinoma
MacroGenicsP1CC (43)
mgc028
Lung Adenocarcinoma
MacroGenicsP1CC (43)
mgd024
CD4+/CD56+ Hematodermic Neoplasm
MacroGenicsP1CC (43)
mgd024
Acute Myeloid Leukemia
MacroGenicsP1CC (43)
mgd024
Lymphoid Leukemia
MacroGenicsP1CC (43)
mgd024
Hairy Cell Leukemia
MacroGenicsP1CC (43)
Mgta-117
Myelodysplastic Syndrome
Magenta Therapeutics, Inc.P1CC (43)
Mib-626
Down Syndrome
Brigham and Women's HospitalP1CC (43)
Micvotabart
Neoplasm
Pyxis Oncology, IncP1CC (43)
Midazolam
Cystic Fibrosis
Vertex Pharmaceuticals IncorporatedP1CC (43)
Midazolam
Glioma
PfizerP1CC (43)
Midazolam
Pancreatic Ductal Adenocarcinoma
Alterome Therapeutics, Inc.P1CC (43)
Midazolam
Thyroid Cancer
PfizerP1CC (43)
Miglustat
Glycogen Storage Disease II
Amicus TherapeuticsP1CC (43)
Minnelide
Pancreatic Adenocarcinoma
Minneamrita Therapeutics LLCP1CC (43)
Minocycline
Neuronitis
University of CincinnatiP1CC (43)
Minocycline
Schizophreniform Disorder
Pakistan Institute of Living and LearningP1CC (43)
Minocycline
Sickle Cell Disease
University of CincinnatiP1CC (43)
Minoxidil
Inherited Disease Susceptibility
Duke UniversityP1CC (43)
Mir-126 Inhibitor Miristen
Acute Myeloid Leukemia
City of Hope Medical CenterP1CC (43)
Mirabegron
Polycystic Ovary Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)P1CC (43)
Showing 3326 to 3350 of 9,920 assets
PreviousPage 134 of 397Next